EUVIMEDEUVIMED entdecken
Crossref

Ishige okamurae Celluclast extract ameliorates non-alcoholic fatty liver in high-fructose diet-fed mice by modulation of lipid metabolism and gut microbiota composition

Seung Tae Im, Haeun Mun, Subin Park, Hyeon Kang, Wook Chul Kim, Soo-Jin Heo, Seung-Hong Lee

Food and Chemical Toxicology · 2023

DOI: 10.1016/j.fct.2023.113864 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Food and Chemical Toxicology, 2023. Verfasst von Seung Tae Im und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Science, Soonchunhyang University, Asan, 31538, Republic of Korea. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 45 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recently, a new mechanism has revealed that gut microbiota plays a pivotal role in metabolizing fructose to acetate that facilitates hepatic lipogenesis. Therefore, our study investigated the role of microbiome on abnormal lipid synthesis in the presence of fructose and identified attenuating effects of Ishige okamurae Celluclast extract (IOCE) against fructose-induced fatty liver. The results indicated that oral administration of IOCE (150 and 300 mg/kg/day for 12 weeks) significantly reduced both gut microbiota-mediated and -non-mediated hepatic lipogenesis simultaneously triggered by fructose metabolism. IOCE reduced hepatic triglyceride accumulation and expression levels of key enzymes for glucolipid metabolism. In addition, IOCE regulated fatty acid synthesis, β-oxidation, and improved hepatic inflammation. Furthermore, IOCE inhibited direct fructose-to-acetate conversion and altered the compositions of gut microbiota. These findings suggest that IOCE might serve as a potential prebiotic dietary supplement by ameliorating fatty liver through dual regulation of classical lipogenic pathway and gut microbiota.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeNon-alcoholic Fatty Liver DiseaseMiceAnimalsLipid MetabolismFructoseDietLiverAcetatesMice, Inbred C57BLDiet, High-Fat

Stichwörter der Autor:innen

Acyl-CoA Synthetase Short chain family member 2Celluclast extractFructose-induced fatty liverGut microbiotaIshige okamurae

Substanzen

FructoseAcetates

Autor:innen und Institutionen

  • Department of Medical Science, Soonchunhyang University, Asan, 31538, Republic of Korea.
  • Jeju Marine Research Center, Korea Institute of Ocean Science and Technology, Jeju, 63349, Republic of Korea. Electronic address: sjheo@kiost.ac.kr.
  • Department of Medical Science, Soonchunhyang University, Asan, 31538, Republic of Korea; Department of Pharmaceutical Engineering, Soonchunhyang University, Asan, 31538, Republic of Korea. Electronic address: seunghong0…

Zitieren

APA

Im, S. T., Mun, H., Park, S., Kang, H., Kim, W. C., Heo, S. J., & Lee, S. H. (2023). Ishige okamurae Celluclast extract ameliorates non-alcoholic fatty liver in high-fructose diet-fed mice by modulation of lipid metabolism and gut microbiota composition. Food and Chemical Toxicology. https://doi.org/10.1016/j.fct.2023.113864

Vancouver

Im ST, Mun H, Park S, Kang H, Kim WC, Heo SJ, et al. Ishige okamurae Celluclast extract ameliorates non-alcoholic fatty liver in high-fructose diet-fed mice by modulation of lipid metabolism and gut microbiota composition. Food and Chemical Toxicology. 2023. doi:10.1016/j.fct.2023.113864

BibTeX
@article{Im2023,
  author = {Im, Seung Tae and Mun, Haeun and Park, Subin and Kang, Hyeon and Kim, Wook Chul and Heo, Soo-Jin and Lee, Seung-Hong},
  title = {Ishige okamurae Celluclast extract ameliorates non-alcoholic fatty liver in high-fructose diet-fed mice by modulation of lipid metabolism and gut microbiota composition},
  journal = {Food and Chemical Toxicology},
  year = {2023},
  doi = {10.1016/j.fct.2023.113864}
}
Kostenlos starten →